Active, not recruitingPhase 2NCT05599360

Vyxeos for Induction of Low- or Intermediate-risk.

Studying Inherited acute myeloid leukemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Shaare Zedek Medical Center
Principal Investigator
Chezi Ganzel, DR, D.O
Shaare Zedek Medical Center
Intervention
Vyxeos(drug)
Enrollment
20 enrolled
Eligibility
18-70 years · All sexes
Timeline
20222028

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05599360 on ClinicalTrials.gov

Other trials for Inherited acute myeloid leukemia

Additional recruiting or active studies for the same condition.

See all trials for Inherited acute myeloid leukemia

← Back to all trials